BACTEROMIC
Antimicrobial Susceptibility Testing (AST) for bacterial infections
DevelopmentActive
Key Facts
Indication
Antimicrobial Susceptibility Testing (AST) for bacterial infections
Phase
Development
Status
Active
Company
About Scope Fluidics
Scope Fluidics is a publicly traded Polish biotech firm leveraging microfluidics to create rapid, point-of-care diagnostic solutions. The company has successfully developed and commercialized its PCR|ONE system through a sale to Bio-Rad and is now advancing its BACTEROMIC system for antimicrobial susceptibility testing. Its core strategy involves incubating innovative projects in separate subsidiaries before forming strategic partnerships or outright sales to large global diagnostics companies for commercialization.
View full company profile